1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione Basic information
- Product Name:
- 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
- Synonyms:
-
- BRD 7389
- 3H-Naphtho[1,2,3-de]quinoline-2,7-dione, 1-[(2-phenylethyl)aMino]-
- 1-[(2-Phenylethyl)amino]-naphtho-3H-[1,2,3-de]quinoline-2,7-dione
- 1-Phenethylamino-3H-naphtho[1,2,3-de]quinoline-2,7-dione
- 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
- Insulin Expression Inducer, BRD7389
- BRD 7389 (BRD7389)
- Insulin Expression Inducer, BRD7389 - CAS 376382-11-5 - Calbiochem
- CAS:
- 376382-11-5
- MF:
- C24H18N2O2
- MW:
- 366.41
- Mol File:
- 376382-11-5.mol
1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione Chemical Properties
- Boiling point:
- 655.0±55.0 °C(Predicted)
- Density
- 1.35±0.1 g/cm3(Predicted)
- storage temp.
- Store at +4°C
- solubility
- DMSO: >20mg/mL
- form
- powder
- pka
- 11.31±0.40(Predicted)
- color
- orange
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione Usage And Synthesis
Description
BRD7389 is an inhibitor of ribosomal S6 kinases (RSKs; IC50s = 1.5, 2.4, and 1.2 μM for RSK1, RSK2, and RSK3, respectively). Through this action, BRD7389 causes mouse αTC1 pancreatic α cells to adopt several morphological and gene expression features of β cells, including increased insulin expression. BRD7389 also enhances glucose-stimulated insulin and glucagon secretion by pancreatic islet cells isolated from human donors with a low body mass index.
Uses
BRD7389 is a specific RSK family kinase inhibitor with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively. BRD7389 is a small-molecule inducer of insulin expression in pancreatic α-cells[1].
Definition
ChEBI: LSM-4550 is a member of anthracenes.
IC 50
RSK1: 1.5 μM (IC50); RSK2: 2.4 μM (IC50); RSK3: 1.2 μM (IC50); CDK5/p35: 6.5 μM (IC50); DRAK1: 2.8 μM (IC50); FLT3: 3.5 μM (IC50); PIM1: 3.7 μM (IC50); PKG1α: 6.5 μM (IC50); SGK: 13.8 μM (IC50)
storage
Store at -20°C
References
[1] DINA FOMINA-YADLIN. Small-molecule inducers of insulin expression in pancreatic alpha-cells.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2010: 15099-15104. DOI:10.1073/pnas.1010018107
[2] AMIT CHOUDHARY. Quantitative-proteomic comparison of alpha and Beta cells to uncover novel targets for lineage reprogramming.[J]. PLoS ONE, 2014: e95194. DOI:10.1371/journal.pone.0095194
[3] YANG-SEO PARK Nam J C. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors.[J]. Molecular and Cellular Biochemistry, 2012, 370 1-2: 191-198. DOI:10.1007/s11010-012-1410-z
1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dioneSupplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 025-846993838003-8003 18013301590
- njduly@126.com
- Tel
- 888-539-0666
- info@emmx.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 021-QQ:65489617 15618227136
- Sales@ATKchemical.com